| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/AJT.14752 |
| P698 | PubMed publication ID | 29603613 |
| P50 | author | Kathryn Tinckam | Q41279089 |
| John J Friedewald | Q42686679 | ||
| Laurie D Snyder | Q56440863 | ||
| Denis Glotz | Q56859181 | ||
| Stuart Knechtle | Q56958780 | ||
| Jon A Kobashigawa | Q64877043 | ||
| Ervin Woodle | Q73677442 | ||
| Stuart Sweet | Q85289246 | ||
| Kenneth A Newell | Q89624884 | ||
| P2093 | author name string | John Smith | |
| Randall C Starling | |||
| Robert L Fairchild | |||
| Michael Mengel | |||
| Ronald G Gill | |||
| Anat R Tambur | |||
| Parmjeet Randhawa | |||
| Adriana Zeevi | |||
| Jacqueline G O'Leary | |||
| Elaine F Reed | |||
| Anne I Dipchand | |||
| Sandy Feng | |||
| Frans H Claas | |||
| Medhat Askar | |||
| Patricia P Chang | |||
| Joshua M Diamond | |||
| Anil Chandraker | |||
| Annette M Jackson | |||
| Craig J Taylor | |||
| Mandy L Ford | |||
| Roslyn B Mannon | |||
| Ramsey Hachem | |||
| Peter Nickerson | |||
| Scott Palmer | |||
| Howard M Gebel | |||
| Patricia Campbell | |||
| Hilary Goldberg | |||
| Monica Colvin | |||
| Edgar Milford | |||
| Deborah J Levine | |||
| Timucin Taner | |||
| Joshua Levitsky | |||
| Anthony-Jake Demetris | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1604-1614 | |
| P577 | publication date | 2018-05-22 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report | |
| P478 | volume | 18 |
| Q99711560 | Analysis of T and B Cell Epitopes to Predict the Risk of de novo Donor-Specific Antibody (DSA) Production After Kidney Transplantation: A Two-Center Retrospective Cohort Study |
| Q90428801 | Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients |
| Q64263915 | Detecting donor-specific antibodies: the importance of sorting the wheat from the chaff |
| Q89910707 | Donor-Specific Antibodies in Liver Transplantation |
| Q93035787 | EDTA Treatment for Overcoming the Prozone Effect and for Predicting C1q Binding in HLA Antibody Testing |
| Q90624940 | Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis |
| Q92429175 | Extracorporeal photopheresis for the treatment of graft rejection in 33 adult kidney transplant recipients |
| Q58555118 | HLA-DR/DQ Molecular Mismatch: A prognostic biomarker for primary alloimmunity |
| Q58780714 | HLA-Epitope Matching or Eplet Risk Stratification: The Devil Is in the Details |
| Q89594061 | Inverse Association Between the Quantity of Human Peripheral Blood CXCR5+IFN-γ+CD8+T cells with De Novo DSA Production in the First Year After Kidney Transplant |
| Q57155622 | New insights into the development of B cell responses: Implications for solid organ transplantation |
| Q98784871 | Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies |
| Q98466664 | Pre-existing Alloreactive T and B Cells and Their Possible Relevance for Pre-transplant Risk Estimation in Kidney Transplant Recipients |
| Q93142076 | Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant |
| Q90110720 | Serum dilutions as a predictive biomarker for peri-operative desensitization: An exploratory approach to transplanting sensitized heart candidates |
| Q60313236 | The Impact of Withdrawal of Maintenance Immunosuppression and Graft Nephrectomy on HLA Sensitization and Calculated Chance of Future Transplant |
| Q93065771 | The impact of alloantibodies directed against the second donor on long-term outcomes of repeat liver transplantation |
| Q90776864 | Time is life: EpAssistant - a new tool for the automatic identification of anti-HLA antibody epitope specificity in transplant programs |
| Q90745717 | Transplanting the Elderly: Mandatory Age- and Minimal Histocompatibility Matching |
| Q89148849 | Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients |
Search more.